Survival analysis and regression models
B George, S Seals, I Aban - Journal of nuclear cardiology, 2014 - Elsevier
… to Figure 1A, since the survival curve for Group 1 decreases faster than Group 2, it is
expected that the hazard function for Group 1 is higher than that of Group 2 as seen in Figure 1B …
expected that the hazard function for Group 1 is higher than that of Group 2 as seen in Figure 1B …
The pattern and outcome of acute severe colitis
…, F Cummings, BF Warren, B George… - Journal of Crohn's …, 2010 - academic.oup.com
… B. Can the violation of another branch of law be relevant for competition law purposes? …
As such, it is in particular inconsistent with the provisions of Article 82 (b) of the Treaty’. …
As such, it is in particular inconsistent with the provisions of Article 82 (b) of the Treaty’. …
Photodegradation and photostabilisation of wood–the state of the art
B George, E Suttie, A Merlin, X Deglise - Polymer degradation and stability, 2005 - Elsevier
In this article we try to give an overview of the photodegradation of wood and the different
ways available to stabilise this complex substrate. The mechanisms of wood photodegradation …
ways available to stabilise this complex substrate. The mechanisms of wood photodegradation …
A draft map of the human proteome
…, L Balakrishnan, J Advani, B George… - Nature, 2014 - nature.com
… b, A heat map showing tissue expression of fetal tissue-restricted genes ordered by average
expression across fetal tissues (left) … b, Overall summary of the results from the current study. …
expression across fetal tissues (left) … b, Overall summary of the results from the current study. …
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor that is upregulated
on activated T cells for the induction of immune tolerance 1 , 2 . Tumour cells frequently …
on activated T cells for the induction of immune tolerance 1 , 2 . Tumour cells frequently …
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
…, J Hofmeijer, E Juettler, E Vicaut, B George… - The Lancet …, 2007 - thelancet.com
Background Malignant infarction of the middle cerebral artery (MCA) is associated with an
80% mortality rate. Non-randomised studies have suggested that decompressive surgery …
80% mortality rate. Non-randomised studies have suggested that decompressive surgery …
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label …
…, V Sharma, R Siegel, W Sun, Z Wainberg, B George… - The Lancet, 2018 - thelancet.com
Background Patients with advanced gastric or gastro-oesophageal junction cancer that
progresses on chemotherapy have poor outcomes. We compared pembrolizumab with paclitaxel …
progresses on chemotherapy have poor outcomes. We compared pembrolizumab with paclitaxel …
[BOOK][B] True north: Discover your authentic leadership
B George - 2010 - books.google.com
… , he has also become more authentic in the sense that Bill George means here—and as a
result, he is … Bill George and his talented younger collaborator in this book, Peter Sims, make a …
result, he is … Bill George and his talented younger collaborator in this book, Peter Sims, make a …
[PDF][PDF] Discovering your authentic leadership
B George, P Sims, AN McLean… - Harvard business …, 2007 - simplylifeindia.com
During the past 50 years, leadership scholars have conducted more than 1,000 studies in
an attempt to determine the definitive styles, characteristics, or personality traits of great …
an attempt to determine the definitive styles, characteristics, or personality traits of great …
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
Background Dual blockade of PD-L1 and VEGF has enhanced anticancer immunity through
multiple mechanisms and augmented antitumour activity in multiple malignancies. We …
multiple mechanisms and augmented antitumour activity in multiple malignancies. We …